News
A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that ...
Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...
Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a ...
Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today ...
Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform ...
What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter ...
Earlier this month, the most recent team-building event saw the Bedfont ® office close for the afternoon, and staff were ...
A new grant from the National Institutes of Health (NIH) will help Wayne State University researchers explore potential ...
Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.
Nearly two-thirds of adults oppose President Donald Trump's "One Big Beautiful Bill" approved in May by the House of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results